Clinical Trial Update: Augmenting Effects of L-DOPS With Carbidopa and Entacapone [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 trial evaluated augmenting the norepinephrine precursor L-DOPS with carbidopa and entacapone in people with Parkinson disease and multiple system…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy
• Parkinson Disease

Drugs mentioned

• Carbidopa (Carbidopa)
• Droxidopa (Droxidopa)
• Entacapone (Entacapone)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson Disease, Multiple System Atrophy | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-07-17